The clash reflects the shifting landscape for weight loss and diabetes drugs, with Novo Nordisk trailing Eli Lilly as companies like Pfizer race to break in.
Czech Prime Minister Andrej Babis wants further negotiations on the European Union's 750 billion euro recovery fund and how the funds are distributed but did not rule out a veto when speaking to lawmakers on Thursday, CTK news agency reported.
